Table 4.
Stage assignment using CT, 18F-FDG PET/CT, and 123I-MIBG SPECT with percentages
| Patients (n) | |||
|---|---|---|---|
| CT | 18F-FDG PET/CT | 123I-MIBG SPECT | |
| Stage 1 | 7/38 (18.4%) | 5/38 (13.1%) | 8/38 (21%) |
| Stage 2 | 11/38 (29%) | 0/38 (0%) | 0/38 (0%) |
| Stage 3 | 6/38 (15.8%) | 0/38 (0%) | 1/38 (2.6%) |
| Stage 4 | 14/38 (36.8%) | 33/38 (86.9%) | 29/38 (76.4%) |